莎普爱思(603168.SH)子公司获得盐酸毛果芸香碱滴眼液临床试验批准通知书

智通财经2025-09-03

智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司全资子公司浙江莎普健康管理有限公司获得国家药品监督管理局核准签发的关于盐酸毛果芸香碱滴眼液的《药物临床试验批准通知书》(通知书编号：2025LP02246)，公司拟于条件具备后开展临床试验。该药品适用于治疗成人老花眼。截至公告披露日，盐酸毛果芸香碱滴眼液项目累计研发投入约644.57万元人民币。

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2564363525?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-09-03 16:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2564363525","market":"hk","top_or_hot":-1,"title":"莎普爱思(603168.SH)子公司获得盐酸毛果芸香碱滴眼液临床试验批准通知书","media":"智通财经","content":"<div>\n<p>智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司全资子公司浙江莎普健康管理有限公司获得国家药品监督管理局核准签发的关于盐酸毛果芸香碱滴眼液的《药物临床试验批准通知书》(通知书编号：2025LP02246)，公司拟于条件具备后开展临床试验。该药品适用于治疗成人老花眼。截至公告披露日，盐酸毛果芸香碱滴眼液项目累计研发投入约644.57万元人民币。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1340980.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>莎普爱思(603168.SH)子公司获得盐酸毛果芸香碱滴眼液临床试验批准通知书</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n莎普爱思(603168.SH)子公司获得盐酸毛果芸香碱滴眼液临床试验批准通知书\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-09-03 16:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1340980.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司全资子公司浙江莎普健康管理有限公司获得国家药品监督管理局核准签发的关于盐酸毛果芸香碱滴眼液的《药物临床试验批准通知书》(通知书编号：2025LP02246)，公司拟于条件具备后开展临床试验。该药品适用于治疗成人老花眼。截至公告披露日，盐酸毛果芸香碱滴眼液项目累计研发投入约644.57万元人民币。</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1340980.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603168","symbol_name":"莎普爱思","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1340980.html","article_id":"2564363525","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2564363525","pubTimestamp":1756886583,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司全资子公司浙江莎普健康管理有限公司获得国家药品监督管理局核准签发的关于盐酸毛果芸香碱滴眼液的《药物临床试验批准通知书》(通知书编号：2025LP02246)，公司拟于条件具备后开展临床试验。该药品适用于治疗成人老花眼。截至公告披露日，盐酸毛果芸香碱滴眼液项目累计研发投入约644.57万元人民币。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603168":"莎普爱思","BK0239":"医药制造"},"translate_title":"Shapuaisi (603168. SH) subsidiary obtained the approval notice for clinical trial of pilocarpine hydrochloride eye drops","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603168":1},"content_text":"智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司全资子公司浙江莎普健康管理有限公司获得国家药品监督管理局核准签发的关于盐酸毛果芸香碱滴眼液的《药物临床试验批准通知书》(通知书编号：2025LP02246)，公司拟于条件具备后开展临床试验。该药品适用于治疗成人老花眼。截至公告披露日，盐酸毛果芸香碱滴眼液项目累计研发投入约644.57万元人民币。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2564363525","isCrawlerRequest":true}